Griffin, M., Gandhi, S., Kelly, R. J., Munir, T., Trikha, R., Hicks, E., Jain, D., Ogawa, M., Yu, J., Muus, P. and Kulasekararaj, A. G. (2020) “Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.285553.